4Evans AM, Faull RJ, Nation RL, et al. Impact of hemodialysis on endogenous plasma and muscle earnitine levels in patients with end-stage renal disease [J]. Kidney Int 2004: 66: 1527-1534.
5Sakurabayashi T, Miyazaki S, Yuasa Y, et al. L-carnitine supplementation decreases the left ventrieular mass in patients undergoing hemodialysis [J]. Circ J, 2008, 72: 926-931.
6Sit D, Kadiroglu AK, Kayabasi H, et al. The prevalence of insulin resistance in nondiabetic nonobese patients with chronic kidney disease [J]. Adv Ther, 2006, 23: 988-998.
7Argani H, Rahbaninoubar M, Ghorbanihagjo A, et al. Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients [J]. Nephrol Clin Pract, 2005, 101: 174-179.
8Signorelli SS, Fatuzzo P, Rapisarda F, et al. Propionyl-L- carnitine therapy: Effects on endothelin-i and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease [J]. Kidney Blood Press Res, 2006. 29:100-107.
9Saviea V, Santoro D, Mazzaglla G, et al. L-carnitine infusions may suppress serum C-reactive protein and im prove nutritional status in maintenance hemodialysis patients [J]. J Ren Nutr, 2005, 15: 225-230.
10Biolo G, Stulle M, Bianco F, et al. Insulin action on glucose and protein metabolism during L-carnitine supple mentation in maintenance hemodialysis patients [J]. Nephrol Dial Transplant, 2008, 23: 991-997.
